Vioxx Lawsuit Given New Life by New Jersey Appeals
According to Reuters News Service, a New Jersey court of appeals
has given new life to a Vioxx lawsuit
brought by plaintiffs who seek Merck & Company, Inc. to pay
for medical monitoring for those who took the drug.
The plaintiffs are seeking a court-ordered
medical screening program from the pharmaceutical company
to test for heart problems arising from the use of the painkiller,
Vioxx. Merck has stated that it will fight the appeal since
it does not believe that plaintiffs will take advantage
of the diagnostic screening if offered.
The painkiller Vioxx was pulled off the market in 2004
when it was linked to increased rate of heart attacks,
stroke and other cardiovascular complications.
Because of the Vioxx lawsuit, other Celebrex
lawsuits and Bextra lawsuits
have taken hold since they are in the same COX 2 selective NSAIDs
class of drugs as Vioxx. Merck has over 140,000 Vioxx lawsuits
pending and says it will fight each case individually rather than
accept any kind of broad settlement negotiation.